Specifically, the ablation of KDM3A enhances tumor‐intrinsic interferon levels through the ERV‐MAVS‐IFN axis, leading to a remodeled TME that effectively inhibits tumor growth. The gene discussed is KDM3A; the disease is neoplasm.